ENTRABODY
DEAD

Serial Number

87150020

Owner

Landing Biotech, Inc.

First Use Date

Dec 28, 2015

Filing Date

Aug 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ENTRABODY Trademark

Serial Number: 87150020 • Registration: 5308014

ENTRABODY is a trademark filed by Landing Biotech, Inc. on August 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Landing Biotech, Inc. (2 trademarks)

Vacaville, CA 95688

Entity Type: 03

Trademark Details

Filing Date

August 24, 2016

Registration Date

October 10, 2017

First Use Anywhere

December 28, 2015

First Use in Commerce

August 1, 2016

Published for Opposition

January 10, 2017

Cancellation Date

April 26, 2024

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 26, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 10, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 8, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 7, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 11, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 11, 2017 AITU
USE AMENDMENT FILED
Jul 17, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 17, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 8, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2016 CNSA
ASSIGNED TO EXAMINER
Dec 4, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2016 NWOS
NEW APPLICATION ENTERED
Aug 27, 2016 NWAP